![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: IL23A |
Gene summary for IL23A |
![]() |
Gene information | Species | Human | Gene symbol | IL23A | Gene ID | 51561 |
Gene name | interleukin 23 subunit alpha | |
Gene Alias | IL-23 | |
Cytomap | 12q13.3 | |
Gene Type | protein-coding | GO ID | GO:0001775 | UniProtAcc | Q9NPF7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51561 | IL23A | LZE7T | Human | Esophagus | ESCC | 3.98e-06 | 2.91e-01 | 0.0667 |
51561 | IL23A | P1T-E | Human | Esophagus | ESCC | 7.43e-09 | 1.20e+00 | 0.0875 |
51561 | IL23A | P2T-E | Human | Esophagus | ESCC | 2.98e-03 | 1.90e-01 | 0.1177 |
51561 | IL23A | P4T-E | Human | Esophagus | ESCC | 8.33e-13 | 3.12e-01 | 0.1323 |
51561 | IL23A | P8T-E | Human | Esophagus | ESCC | 3.75e-02 | 9.40e-02 | 0.0889 |
51561 | IL23A | P11T-E | Human | Esophagus | ESCC | 1.72e-04 | 5.52e-01 | 0.1426 |
51561 | IL23A | P23T-E | Human | Esophagus | ESCC | 4.42e-05 | 1.46e-01 | 0.108 |
51561 | IL23A | P26T-E | Human | Esophagus | ESCC | 3.11e-06 | 1.75e-01 | 0.1276 |
51561 | IL23A | P37T-E | Human | Esophagus | ESCC | 3.53e-03 | 1.04e-01 | 0.1371 |
51561 | IL23A | P49T-E | Human | Esophagus | ESCC | 6.53e-04 | 4.81e-01 | 0.1768 |
51561 | IL23A | P52T-E | Human | Esophagus | ESCC | 2.93e-08 | 2.62e-01 | 0.1555 |
51561 | IL23A | P54T-E | Human | Esophagus | ESCC | 2.11e-02 | 1.81e-01 | 0.0975 |
51561 | IL23A | P62T-E | Human | Esophagus | ESCC | 5.60e-04 | 1.37e-01 | 0.1302 |
51561 | IL23A | P76T-E | Human | Esophagus | ESCC | 2.52e-04 | 2.32e-01 | 0.1207 |
51561 | IL23A | P83T-E | Human | Esophagus | ESCC | 1.84e-08 | 4.57e-01 | 0.1738 |
51561 | IL23A | P89T-E | Human | Esophagus | ESCC | 3.35e-02 | 2.88e-01 | 0.1752 |
51561 | IL23A | P126T-E | Human | Esophagus | ESCC | 7.86e-04 | 2.97e-01 | 0.1125 |
51561 | IL23A | P128T-E | Human | Esophagus | ESCC | 1.91e-31 | 9.38e-01 | 0.1241 |
51561 | IL23A | P130T-E | Human | Esophagus | ESCC | 2.02e-17 | 5.24e-01 | 0.1676 |
51561 | IL23A | C21 | Human | Oral cavity | OSCC | 5.36e-04 | 2.28e-01 | 0.2678 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000961518 | Esophagus | ESCC | response to virus | 238/8552 | 367/18723 | 6.65e-14 | 3.32e-12 | 238 |
GO:00516075 | Esophagus | ESCC | defense response to virus | 171/8552 | 265/18723 | 3.91e-10 | 1.05e-08 | 171 |
GO:01405465 | Esophagus | ESCC | defense response to symbiont | 171/8552 | 265/18723 | 3.91e-10 | 1.05e-08 | 171 |
GO:0030099111 | Esophagus | ESCC | myeloid cell differentiation | 232/8552 | 381/18723 | 1.22e-09 | 2.90e-08 | 232 |
GO:004578527 | Esophagus | ESCC | positive regulation of cell adhesion | 255/8552 | 437/18723 | 5.07e-08 | 9.11e-07 | 255 |
GO:00028318 | Esophagus | ESCC | regulation of response to biotic stimulus | 191/8552 | 327/18723 | 2.12e-06 | 2.45e-05 | 191 |
GO:000257317 | Esophagus | ESCC | myeloid leukocyte differentiation | 128/8552 | 208/18723 | 2.75e-06 | 3.15e-05 | 128 |
GO:004586018 | Esophagus | ESCC | positive regulation of protein kinase activity | 219/8552 | 386/18723 | 6.91e-06 | 6.97e-05 | 219 |
GO:003367420 | Esophagus | ESCC | positive regulation of kinase activity | 260/8552 | 467/18723 | 7.26e-06 | 7.22e-05 | 260 |
GO:1903706110 | Esophagus | ESCC | regulation of hemopoiesis | 201/8552 | 367/18723 | 2.60e-04 | 1.58e-03 | 201 |
GO:19021076 | Esophagus | ESCC | positive regulation of leukocyte differentiation | 93/8552 | 157/18723 | 4.20e-04 | 2.39e-03 | 93 |
GO:19037086 | Esophagus | ESCC | positive regulation of hemopoiesis | 93/8552 | 157/18723 | 4.20e-04 | 2.39e-03 | 93 |
GO:004563918 | Esophagus | ESCC | positive regulation of myeloid cell differentiation | 64/8552 | 103/18723 | 5.54e-04 | 3.03e-03 | 64 |
GO:002240720 | Esophagus | ESCC | regulation of cell-cell adhesion | 239/8552 | 448/18723 | 5.88e-04 | 3.19e-03 | 239 |
GO:00506884 | Esophagus | ESCC | regulation of defense response to virus | 45/8552 | 69/18723 | 8.26e-04 | 4.27e-03 | 45 |
GO:004211018 | Esophagus | ESCC | T cell activation | 256/8552 | 487/18723 | 1.18e-03 | 5.87e-03 | 256 |
GO:19031317 | Esophagus | ESCC | mononuclear cell differentiation | 226/8552 | 426/18723 | 1.20e-03 | 5.88e-03 | 226 |
GO:00182124 | Esophagus | ESCC | peptidyl-tyrosine modification | 202/8552 | 378/18723 | 1.34e-03 | 6.39e-03 | 202 |
GO:0045637111 | Esophagus | ESCC | regulation of myeloid cell differentiation | 118/8552 | 210/18723 | 1.35e-03 | 6.43e-03 | 118 |
GO:002240919 | Esophagus | ESCC | positive regulation of cell-cell adhesion | 155/8552 | 284/18723 | 1.50e-03 | 7.06e-03 | 155 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa046259 | Esophagus | ESCC | C-type lectin receptor signaling pathway | 73/4205 | 104/8465 | 1.57e-05 | 7.98e-05 | 4.09e-05 | 73 |
hsa051527 | Esophagus | ESCC | Tuberculosis | 111/4205 | 180/8465 | 7.14e-04 | 2.32e-03 | 1.19e-03 | 111 |
hsa046599 | Esophagus | ESCC | Th17 cell differentiation | 68/4205 | 108/8465 | 3.53e-03 | 9.30e-03 | 4.76e-03 | 68 |
hsa0532320 | Esophagus | ESCC | Rheumatoid arthritis | 59/4205 | 93/8465 | 4.98e-03 | 1.27e-02 | 6.52e-03 | 59 |
hsa051339 | Esophagus | ESCC | Pertussis | 48/4205 | 76/8465 | 1.21e-02 | 2.77e-02 | 1.42e-02 | 48 |
hsa0462513 | Esophagus | ESCC | C-type lectin receptor signaling pathway | 73/4205 | 104/8465 | 1.57e-05 | 7.98e-05 | 4.09e-05 | 73 |
hsa0515212 | Esophagus | ESCC | Tuberculosis | 111/4205 | 180/8465 | 7.14e-04 | 2.32e-03 | 1.19e-03 | 111 |
hsa0465914 | Esophagus | ESCC | Th17 cell differentiation | 68/4205 | 108/8465 | 3.53e-03 | 9.30e-03 | 4.76e-03 | 68 |
hsa05323110 | Esophagus | ESCC | Rheumatoid arthritis | 59/4205 | 93/8465 | 4.98e-03 | 1.27e-02 | 6.52e-03 | 59 |
hsa0513314 | Esophagus | ESCC | Pertussis | 48/4205 | 76/8465 | 1.21e-02 | 2.77e-02 | 1.42e-02 | 48 |
hsa046258 | Oral cavity | OSCC | C-type lectin receptor signaling pathway | 73/3704 | 104/8465 | 3.83e-08 | 3.12e-07 | 1.59e-07 | 73 |
hsa051526 | Oral cavity | OSCC | Tuberculosis | 105/3704 | 180/8465 | 5.00e-05 | 2.04e-04 | 1.04e-04 | 105 |
hsa051338 | Oral cavity | OSCC | Pertussis | 50/3704 | 76/8465 | 8.34e-05 | 3.04e-04 | 1.55e-04 | 50 |
hsa046598 | Oral cavity | OSCC | Th17 cell differentiation | 65/3704 | 108/8465 | 4.02e-04 | 1.25e-03 | 6.35e-04 | 65 |
hsa0532318 | Oral cavity | OSCC | Rheumatoid arthritis | 56/3704 | 93/8465 | 9.72e-04 | 2.76e-03 | 1.40e-03 | 56 |
hsa0462512 | Oral cavity | OSCC | C-type lectin receptor signaling pathway | 73/3704 | 104/8465 | 3.83e-08 | 3.12e-07 | 1.59e-07 | 73 |
hsa0515211 | Oral cavity | OSCC | Tuberculosis | 105/3704 | 180/8465 | 5.00e-05 | 2.04e-04 | 1.04e-04 | 105 |
hsa0513313 | Oral cavity | OSCC | Pertussis | 50/3704 | 76/8465 | 8.34e-05 | 3.04e-04 | 1.55e-04 | 50 |
hsa0465913 | Oral cavity | OSCC | Th17 cell differentiation | 65/3704 | 108/8465 | 4.02e-04 | 1.25e-03 | 6.35e-04 | 65 |
hsa0532319 | Oral cavity | OSCC | Rheumatoid arthritis | 56/3704 | 93/8465 | 9.72e-04 | 2.76e-03 | 1.40e-03 | 56 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
IL23A | SNV | Missense_Mutation | c.356N>A | p.Ser119Asn | p.S119N | Q9NPF7 | protein_coding | deleterious(0.04) | benign(0.029) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
IL23A | insertion | Frame_Shift_Ins | novel | c.545_546insCTTCCACT | p.Gly183PhefsTer8 | p.G183Ffs*8 | Q9NPF7 | protein_coding | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
IL23A | insertion | Frame_Shift_Ins | novel | c.547_548insCTTT | p.Gly183AlafsTer28 | p.G183Afs*28 | Q9NPF7 | protein_coding | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
IL23A | SNV | Missense_Mutation | c.313N>C | p.Gly105Arg | p.G105R | Q9NPF7 | protein_coding | deleterious(0) | probably_damaging(0.93) | TCGA-DD-A4NR-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
IL23A | SNV | Missense_Mutation | c.226G>A | p.Gly76Ser | p.G76S | Q9NPF7 | protein_coding | tolerated(0.12) | benign(0.423) | TCGA-CG-4301-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
IL23A | SNV | Missense_Mutation | rs146998334 | c.473N>A | p.Arg158His | p.R158H | Q9NPF7 | protein_coding | deleterious(0.03) | probably_damaging(0.998) | TCGA-HU-A4H8-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | didox | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
51561 | IL23A | DRUGGABLE GENOME | BRIAKINUMAB | BRIAKINUMAB | ||
51561 | IL23A | DRUGGABLE GENOME | Ustekinumab | USTEKINUMAB | ||
51561 | IL23A | DRUGGABLE GENOME | ustekinumab | USTEKINUMAB | ||
51561 | IL23A | DRUGGABLE GENOME | inhibitor | CHEMBL1742995 | BRIAKINUMAB | |
51561 | IL23A | DRUGGABLE GENOME | CNTO 1275 | |||
51561 | IL23A | DRUGGABLE GENOME | AMG-139 | BRAZIKUMAB | ||
51561 | IL23A | DRUGGABLE GENOME | USTEKINUMAB | USTEKINUMAB | ||
51561 | IL23A | DRUGGABLE GENOME | Ustekinumab | USTEKINUMAB | ||
51561 | IL23A | DRUGGABLE GENOME | USTEKINUMAB | USTEKINUMAB | ||
51561 | IL23A | DRUGGABLE GENOME | Tildrakizumab | TILDRAKIZUMAB |
Page: 1 2 |